DRA ROSINACH

Mercè Rosinach

Especialidad: Aparato Digestivo
Especialidad: Digestólogo
Hospitales donde trabaja:
  • Centro Médico Teknon
Especialidades que atiende:
  • Digestólogo
Titulación
  • Medicina y Cirurgia en la Universidad Central de Lérida en 1995.
  • Especialidad Aparato Digestivo Hospital Germans Trias i Pujol en el periodo comprendido del 1999-2003.
  • Médico Residente en Hospital Germans Trias i Pujol Badaloma de 1999-2003.
  • Médico Adjunto al Servicio de Gastroenterologia desde 2003- 2017 ( contrato 40 horas tiempo completo ) en Hospital Universitario Mutua de Terrassa.

1.- Fernandez-Banares F, Rosinach M, Esteve M, Forne M, Espinos JC, Viver J.M. Sugar malabsorption in functional abdominal bloating: A pilot study on the long-term effect of dietary treatment. Clin Nutr. 2006 Oct; 25 (5): 824-31.

2.- Esteve M, Rosinach M, Fernandez-Banares F, Farre C, Salas A, Alsina M, Vilar, P, Abad-Lacruz A, Forne M, Marine M, Santaolalla R, Espinos JC, Viver Spectrum of gluten sensitive enteropathy in first degree relatives of coeliac patients: clinical relevance of lymphocytic enteritis. JM. Gut . 2006 Dec; 55(12): 1739-45.

3.- Fernandez-Bañares F, Esteve M, Espinós JC, Rosinach M, Forné M, Salas A, Viver JM. Drug consumption and risk of microscopic colitis. Am J Gastroenterol 2006;101:1-7.

4.-Fernandez-Banares F, Esteve M, Salas A, Alsina M, Farré C, Gonzalez C, Buxeda M, Forné M, Rosinach M, Espinós JC, Viver JM. Systematic evaluation of causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol. 2007; 102:2520-8.

5.- Santaolalla R, Fernandez-Bañares F, Rodríguez R, Alsina M, Rosinach M, Mariné M, Farré C, Salas A, Forné M, Loras C, Espinós JC, Viver JM , Esteve. Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enterophathy. Aliment Pharrmacol Ther 2008; 27: 820-9.

6.-Domènech E, Vega R, Ojanguren I, Hernández A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E, Gassull MA. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008 Oct;14(10):1373-9.

7.- Forné M, Fernández-Bañares F, González-Mínguez C, Casalots J, Poblet-Mas N, Garcia-Gil LJ, Esteve M, Rosinach M, Espinós J, Loras C, Salas A, Viver JM. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.Am J Clin Pathol. 2009 Jan;131(1):99-105.

8.- Paucicellular lymphocytic colitis: is it a minor form of lymphocytic colitis? A clinical pathological and immunological study. Fernández-Bañares F, Casalots J, Salas A, Esteve M, Rosinach M, Forné M, Loras C, Santaolalla R, Espinós J, Viver JM. Am J Gastroenterol. 2009 May;104(5):1189-98.

9.- Evolution of the incidence of collagenousc colitis and lymphocytic colitis in Terrassa, Spain: a population-based study.Fernández-Bañares F, Salas A, Esteve M, Pardo L, Casalots J, Forné M, Espinós JC, Loras C, Rosinach M, Viver JM. Inflamm Bowel Dis. 2011 Apr;17(4):1015-20.

10.-The prevalence of coeliac disease is significantly higher in children compared with adults. Mariné M, Farre C, Alsina M, Vilar P, Cortijo M, Salas A, Fernández-Bañares F, Rosinach M, Santaolalla R, Loras C, Marquès T, Cusí V, Hernández MI, Carrasco A, Ribes J, Viver JM, Esteve M. Aliment Pharmacol Ther. 2011 Feb;33(4):477-86.

11.- Mild enteropathy as a cause of iron-deficiency anaemia of previously unknown origin. Monzón H, Forné M, González C, Esteve M, Martí JM, Rosinach M, Mariné M, Loras C, Espinós JC, Salas A, Viver JM, Fernández-Bañares F. Dig Liver Dis. 2011 Jun;43(6):448-53.

12.-Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease. Santaolalla R, Mañé J, Pedrosa E, Lorén V, Fernández-Bañares F, Mallolas J,Carrasco A, Salas A, Rosinach M, Forné M, Espinós JC, Loras C, Donovan M, Puig P, Mañosa M, Gassull MA, Viver JM, Esteve M. Inflamm Bowel Dis. 2011 Jul;17(7):1490-500.

13.-Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease. Fernández-Bañares F, Alsina M, Modolell I, Andújar X, Piqueras M, García-Puig R, Martín B, Rosinach M, Salas A, Viver JM, Esteve M. J Crohns Colitis. 2012 Feb 15.

14.- Lymphocytic duodenosis: Aetiology and long-term response to specific treatment. Rosinach M, Esteve M, Gonzalez C, Temiño R, Mariné M, Monzón H, Sainz E, Loras C, Espinós JC, Forné M, Viver JM, Salas A, Fernández- Bañares F. Dig Liver 2012 Aug; 44 (8): 643-8.

15.- Comment to "High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of coeliac disease". Fernández-Bañares F, Rosinach M, Esteve M. Dig Liver Dis. 2012 Oct;44(10):885-6.

16.- Comparison of lymphocyte isolation methods for endoscopic biopsy specimens from the colonic mucosa.Carrasco A, Mañe J, Santaolalla R, Pedrosa E, Mallolas J, Lorén V, Fernández M, Fernández-Bañares F, Rosinach M, Loras C, Forné M, Andújar X, Vidal J, Viver JM, Esteve M. J Immunol Methods. 2013 Mar 29;389(1-2):29-37.

17.-Helicobacter pylori infection as a cause of iron deficiency anaemia of unknown origin. Monzón H, Forné M, Esteve M, Rosinach M, Loras C, Espinós JC, Viver JM, Salas A, Fernández-Bañares F.World J Gastroenterol. 2013 Jul 14;19(26):4166-71

18.-Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) Survey, a specific questionnaire to measure quality of life in patients with celiac disease.Casellas F, Rodrigo L, Molina-Infante J, Vivas S, Lucendo AJ, Rosinach M, Dueñas C, Fernández-Bañares F, López-Vivancos J.Rev Esp Enferm Dig. 2013 Nov-Dec;105(10):585-93.

19.-Intestinal intraepithelial lymphocyte cytometric pattern is more accurate than subepithelial deposits of anti-tissue transglutaminase IgA for the diagnosis of celiac disease in lymphocytic enteritis. Fernández-Bañares F, Carrasco A, García-Puig R, Rosinach M, González C, Alsina M, Loras C, Salas A, Viver JM, Esteve M.PLoS One. 2014 Jul 10;9(7):e101249.

20.-Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Nicholl AG, Forné M, Barrio J, De la Coba C, González B, Rivera R, Esteve M, Fernandez-Bañares F, Madrigal B, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras C, Esteban C, Santolaria S, Gomollon F, Valle J, Gisbert JP; Helicobacter pylori Study Group of Asociación Española de Gastroenterología (AEG).Eur J Gastroenterol Hepatol. 2014 Sep;26(9):941-8

21.-Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies:multicenter prospective observational study ( REPENTINE3). Loras C, Gisbert JP, Saro MC, Piqueras M, Snchez-Montes C, Barrio J, Ords I, Montserrat A, Ferreiro R, Zabana Y, Chaparro M, Fernndez-Bañares F, Esteve M; Repentina study,J Crohns Colitis.2014 Nov;8 (11):1529-38

22.- Benefit on health-related qualityof life of adhernce to gluten-free diet in adult patients with celiac disease; Casellas F, Rodrigo L, Lucendo AJ, Fernandez-Bañares F, Molina-Infante J, Vivas S, Rosinach M, Dueñas C, Lopez-Vivancos J;Rev Esp Enferm Dig.2015 Apr;107 (4):196-201

23.- Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea. Fernández-Bañares F, Rosinach M, Piqueras M, Ruiz-Cerulla A, Modolell I, Zabana Y, Guardiola J, Esteve M. Aliment Pharmacol Ther. 2015 Jun;41(11):1132-40.

24.-Imnunological differences between Lymphocytic Collagenous Colitis ; Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, Zabana Y, Fernandez-Bañares F;J Crohns Colitis. 2016 Sep;10(9):1055-66.

25.-Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Deseases.Carrasco A, Fernández-Bañares F, Pedrosa E, Salas A, Loras C,Rosinach M, Aceituno M, Andújar X, Forné M, Zabana Y, Esteve MJ Crohns Colitis. 2016 Sep;10(9):1042-54.

26.- Double-blind randomized clinical trial: Gluten versus placebo rechallenge in patients with lymphocytic enteriritis and suspected celiac disease; Rosinach M, Fernandez -Bañares F, Carrasco A, Ibarra M, Temiño R, Salas A, Esteve M; PLoS One. 2016 Jul 8;11(7).

27.-Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.Comino I, Fernández-Bañares F, Esteve M, Ortigosa L, Castillejo G,

Fambuena B, Ribes-Koninckx C, Sierra C, Rodríguez-Herrera A, Salazar JC, Caunedo Á, Marugán-Miguelsanz JM, Garrote JA, Vivas S, Lo Iacono O, Nuñez A, Vaquero L, Vegas AM, Crespo L, Fernández-Salazar L, Arranz E, Jiménez-García VA, Antonio Montes-Cano M, Espín B, Galera A, Valverde J, Girón FJ, Bolonio M, Millán A, Cerezo FM, Guajardo C, Alberto JR, Rosinach M, Segura V, León F, Marinich J, Muñoz-Suano A, Romero-Gómez M, Cebolla Á, Sousa C.Am J Gastroenterol. 2016 Oct;111(10):1456-1465

28.- Fernández-Bañares F, Arau B, Dieli-Crimi R, Rosinach M, Nuñez C, Esteve M. Systematic Review and Meta-analysis Show 3% of Patients With Celiac Disease in Spain to be Negative for HLA-DQ2.5 and HLA-DQ8. Clin Gastroenterol Hepatol. 2016 Oct 14.

29.- Batista L, Pérez Jove J, Rosinach M, Gonzalo V, Sainz E, Loras C, Forné M, Esteve M, Fernández-Bañares F. Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review. Gastroenterol Hepatol. 2017 Mar 6.